• Search

Blog

Can We Model Neuroimmune Diseases in a Dish?

Can We Model Neuroimmune Diseases in a Dish?

Following Axol Bioscience and Censo Biotechnologies recent merger to form Axol Biosciences, our CSO Ashley Barnes was invited to speak at the Neuroimmunology Drug Development Summit alongside other experts from academia and industry on the advances being made in this burgeoning field.

In this article we feature his answers to some of the pressing questions that arose from the audience and the field.  
From Comedy and Pop Culture to Science:  The 10th Forum of Neuroscience in Copenhagen

From Comedy and Pop Culture to Science: The 10th Forum of Neuroscience in Copenhagen

Axol Bioscience sponsored Austrian Neuroscience Association (ANA) Student, Michael Stefan Unger to attend the 10th Forum for Neuroscience Societies (FENS), which took place in Copenhagen, Denmark. Michael is a PhD student at the Institute of Molecular Regenerative Medicine, Paracelsus Medical University in Salzburg, Austria. His PhD research focuses on cellular plasticity associated with amyloid-plaques and the potential role of neurogenic cells in modulating plaque pathology in Alzheimer's disease. Michael writes about his research and shares his experience of the conference.

Nurturing Neuroscience

Nurturing Neuroscience

Our understanding of the central nervous system (CNS) has grown significantly in recent years. The advent of new technologies and products have enabled us to explore not only the molecular mechanisms involved in learning, development, memory formation, electrical conductivity and synaptic function but also the onset and deterioration of these systems in neurological disorders such as epilepsy, amyotrophic lateral sclerosis (ALS), Alzheimer’s, Huntington’s and Parkinson’s diseases as well as psychiatric conditions.